Skip to main content
Button to close investor relations menu

    Welcome

    United Therapeutics is the first publicly-traded biotech or pharmaceutical company to take the form of a public benefit corporation. Our public benefit purpose is to provide a brighter future for patients through (a) the development of novel pharmaceutical therapies; and (b) technologies that expand the availability of transplantable organs.

    United Therapeutics
    Telephone: 301-608-9292
    Email: ir@unither.com



    To contact our Transfer Agent:

    Mailing address:
    Computershare
    P.O. Box 43006
    Providence, RI 02940-3006

    Courier delivery:
    Computershare
    150 Royall St., Suite 101
    Canton, MA 02021

    Website:
    www.computershare.com/investor

    Tel: 1 (201) 680-6578
    Toll Free: (800) 524-4458

    Contact